MedTrace Logo

Prediction of Clinical Response and Outcome in Uterine Cervix Cancer

NCT01764217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-03-30

No results posted yet for this study

Summary

Observational study based on the routine clinical treatment and diagnostic course, to correlate imaging features with outcome objectives. Outcome will evaluated as clinical response to the standard treatment and as recurrence and survival in the follow up. The study hypothesis is that data extracted form FDG-PETCT used in the routine clinical practice can predict outcomes following standard treatment.

Conditions

  • Cervix Cancer

Sponsors & Collaborators

  • Maastricht University Medical Center

    collaborator OTHER

  • Maastricht Radiation Oncology

    lead OTHER

Principal Investigators

  • philippe Lambin · Maastro Clinic, The Netherlands

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2006-07-31
Completion
2013-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01764217 on ClinicalTrials.gov